Orion Oyj Management
Management criteria checks 3/4
Orion Oyj's CEO is Liisa Hurme, appointed in Jan 2019, has a tenure of 5.83 years. total yearly compensation is €819.50K, comprised of 81.6% salary and 18.4% bonuses, including company stock and options. directly owns 0.023% of the company’s shares, worth €1.42M. The average tenure of the management team and the board of directors is 2 years and 4.5 years respectively.
Key information
Liisa Hurme
Chief executive officer
€819.5k
Total compensation
| CEO salary percentage | 81.6% |
| CEO tenure | 5.8yrs |
| CEO ownership | 0.02% |
| Management average tenure | 2yrs |
| Board average tenure | 4.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | €332m |
| Jun 30 2024 | n/a | n/a | €232m |
| Mar 31 2024 | n/a | n/a | €217m |
| Dec 31 2023 | €820k | €668k | €217m |
| Sep 30 2023 | n/a | n/a | €173m |
| Jun 30 2023 | n/a | n/a | €306m |
| Mar 31 2023 | n/a | n/a | €336m |
| Dec 31 2022 | €106k | €106k | €350m |
Compensation vs Market: Liisa's total compensation ($USD862.72K) is about average for companies of similar size in the Finnish market ($USD1.02M).
Compensation vs Earnings: Liisa's compensation has increased by more than 20% in the past year.
CEO
Liisa Hurme (57 yo)
5.8yrs
Tenure
€819,500
Compensation
Dr. Liisa Hurme, PhD (Biochemistry), has been President , Chief Executive Officer and Chairman of Managemenbt board at Orion Oyj since Novemnber 01, 2022. Dr. Hurme served as Senior Vice President, Global...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 5.8yrs | €819.50k | 0.023% € 1.4m | |
| Chief Financial Officer & Member of Group Executive Management Board | less than a year | no data | no data | |
| Senior VP of Corporate Functions | 22.1yrs | no data | 0.060% € 3.7m | |
| Senior VP of Generics and Consumer Health Business Division & Member of the Exe. Mgmt. Board | 16.8yrs | no data | 0.025% € 1.5m | |
| Sr. VP of Innovative Medicines | 4.4yrs | no data | 0.010% € 640.0k | |
| Senior VP of Global Operations & Member of Executive Management Board | 2yrs | no data | 0.0036% € 223.4k | |
| Senior VP of Animal Health Business Division & Member of the Exe. Mgmt. Board | 1.8yrs | no data | 0.0031% € 191.4k | |
| Senior VP of the Branded Products Business Division & Member of the Exe. Mgmt. Board | 1.8yrs | no data | 0.010% € 651.3k | |
| Senior Vice President of People & Culture and Member of Management Board | less than a year | no data | no data | |
| Investor Relations & Financial Communications Officer | no data | no data | no data | |
| Vice President of Communications | 15.6yrs | no data | no data | |
| Sr. VP of Corporate Strategy and Program Mgmt. Grp. Level Function & Head of CSPMO | less than a year | no data | 0.023% € 1.4m |
2.0yrs
Average Tenure
55yo
Average Age
Experienced Management: ORNAV's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 10.7yrs | €123.40k | 0.0069% € 433.6k | |
| Independent Chairman | 3.7yrs | €61.40k | 0.0066% € 412.9k | |
| Director | less than a year | no data | no data | |
| Independent Director | 4.5yrs | €61.40k | 0.062% € 3.9m | |
| Independent Director | 7.7yrs | €72.40k | 0.0036% € 227.1k | |
| Independent Director | 2.7yrs | €60.80k | 0.0011% € 67.6k | |
| Independent Director | 8.7yrs | €61.40k | 0.41% € 25.7m | |
| Independent Vice Chairman of the Board | 7.7yrs | €81.10k | 0.0073% € 454.8k | |
| Independent Director | 2.7yrs | €66.80k | 0.0011% € 67.6k |
4.5yrs
Average Tenure
62yo
Average Age
Experienced Board: ORNAV's board of directors are considered experienced (4.5 years average tenure).